November 25, 2020
During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia who is based at Weill Cornell Medicine, New York, US. We asked, "How do you decide what clinical trial to pick?". In this video, Gail describes the features that the treating clinician might look at, such as if the drug or mechanism is different from what the patient has had before. She also describes other important features that need to be considered including the toxicity profile, feasibility, and logistics.